BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19555146)

  • 1. Concurrent use of statins and amiodarone.
    Borders-Hemphill V
    Consult Pharm; 2009 May; 24(5):372-9. PubMed ID: 19555146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center.
    Karimi S; Hough A; Beckey C; Parra D
    J Manag Care Pharm; 2010 Sep; 16(7):472-81. PubMed ID: 20726676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis in association with simvastatin and amiodarone.
    Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
    Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a pharmacist-managed amiodarone monitoring program.
    Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH
    J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gluteal rhabdomyolysis and renal failure due to simvastatin and amiodarone.
    Semmo M; Dhayat NA
    Kidney Int; 2016 Oct; 90(4):909. PubMed ID: 27633874
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis after addition of digitoxin to chronic simvastatin and amiodarone therapy.
    Nägele H; Behrens S; Hashagen S; Azizi M
    Drug Metabol Drug Interact; 2007; 22(2-3):195-200. PubMed ID: 17708069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.
    Milner E; Ainsworth M; Gleaton M; Bookstaver D
    J Clin Pharm Ther; 2022 May; 47(5):668-675. PubMed ID: 35032137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing.
    Prom R; Umscheid CA; Kasbekar N; Spinler SA
    Am J Health Syst Pharm; 2013 Nov; 70(21):1878-9. PubMed ID: 24128959
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.
    Schmidt GA; Hoehns JD; Purcell JL; Friedman RL; Elhawi Y
    J Am Board Fam Med; 2007; 20(4):411-6. PubMed ID: 17615423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events with concomitant amiodarone and statin therapy.
    Alsheikh-Ali AA; Karas RH
    Prev Cardiol; 2005; 8(2):95-7. PubMed ID: 15860984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management.
    Zhou YT; Yu LS; Zeng S; Huang YW; Xu HM; Zhou Q
    Ther Clin Risk Manag; 2014; 10():17-26. PubMed ID: 24379677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brown urine : Myoglobin-induced renal failure after concomitant administration of simvastatin and amiodarone].
    Pietsch U; Müller-Höcker C; Filipovic M
    Anaesthesist; 2016 May; 65(5):366-8. PubMed ID: 27142363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Ronaldson KJ; O'Shea JM; Boyd IW
    Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
    Strandell J; Bate A; Hägg S; Edwards IR
    Br J Clin Pharmacol; 2009 Sep; 68(3):427-34. PubMed ID: 19740401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin safety and drug interactions: clinical implications.
    Bottorff MB
    Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register study.
    Settergren J; Eiermann B; Mannheimer B
    PLoS One; 2013; 8(8):e69545. PubMed ID: 23940522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].
    Bastida C; Also MA; Pericas JM; Letang E; Tuset M; Miró JM
    Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):579-82. PubMed ID: 24913991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study.
    Tirkkonen T; Ryynänen A; Vahlberg T; Irjala K; Klaukka T; Huupponen R; Laine K
    Drug Saf; 2008; 31(3):231-40. PubMed ID: 18302447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population.
    Bakhai A; Rigney U; Hollis S; Emmas C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):485-93. PubMed ID: 22237927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin dosing restrictions; monitoring amiodarone therapy.
    DeDea L
    JAAPA; 2011 Sep; 24(9):16. PubMed ID: 21905458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.